Givinostat also has been tested in adults with Becker muscular dystrophy. Top-line results from a Phase 2 trial (NCT03238235) showed that treatment failed to reduce muscle scarring, a main trial goal, but its use stopped further muscle shrinkage and fat infiltration, suggesting it may slow or prevent disease progression.
I wasnt correct in what I said about the adult trial.
For General Information, page-2663
-
- There are more pages in this discussion • 864 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
